BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35996251)

  • 1. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation in DNMT3B gene causing ICF1 syndrome in an infant with refractory thrombocytopenia.
    Baris S; Boluk SO
    Clin Immunol; 2023 Nov; 256():109779. PubMed ID: 37741519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency, Centromeric Region Instability, and Facial Anomalies Syndrome (ICF) in a Boy with Variable Clinical and Immunological Presentations.
    Bemanian MH; Arshi S; Nabavi M; Vafaee-Shahi M; Fallahpour M; Shokri S; Rezaeifar A; Shahzadi H; Atashrazm F
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):249-254. PubMed ID: 33904683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicourethral reflux-induced renal failure in a patient with ICF syndrome due to a novel DNMT3B mutation.
    Kutluğ S; Ogur G; Yilmaz A; Thijssen PE; Abur U; Yildiran A
    Am J Med Genet A; 2016 Dec; 170(12):3253-3257. PubMed ID: 27604394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
    Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Immunological Characterization of ICF Syndrome in Japan.
    Kamae C; Imai K; Kato T; Okano T; Honma K; Nakagawa N; Yeh TW; Noguchi E; Ohara A; Shigemura T; Takahashi H; Takakura S; Hayashi M; Honma A; Watanabe S; Shigemori T; Ohara O; Sasaki H; Kubota T; Morio T; Kanegane H; Nonoyama S
    J Clin Immunol; 2018 Nov; 38(8):927-937. PubMed ID: 30353301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).
    Ehrlich M; Jackson K; Weemaes C
    Orphanet J Rare Dis; 2006 Mar; 1():2. PubMed ID: 16722602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.
    Lana E; Mégarbané A; Tourrière H; Sarda P; Lefranc G; Claustres M; De Sario A
    Eur J Hum Genet; 2012 Oct; 20(10):1044-50. PubMed ID: 22378288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Types of Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome Identified by Whole-Exome Sequencing in Saudi Hypogammaglobulinemia Patients: Clinical, Molecular, and Cytogenetic Features.
    Alghamdi HA; Tashkandi SA; Alidrissi EM; Aledielah RD; AlSaidi KA; Alharbi ES; Habazi MK; Alzahrani MS
    J Clin Immunol; 2018 Nov; 38(8):847-853. PubMed ID: 30511102
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.
    Weemaes CM; van Tol MJ; Wang J; van Ostaijen-ten Dam MM; van Eggermond MC; Thijssen PE; Aytekin C; Brunetti-Pierri N; van der Burg M; Graham Davies E; Ferster A; Furthner D; Gimelli G; Gennery A; Kloeckener-Gruissem B; Meyn S; Powell C; Reisli I; Schuetz C; Schulz A; Shugar A; van den Elsen PJ; van der Maarel SM
    Eur J Hum Genet; 2013 Nov; 21(11):1219-25. PubMed ID: 23486536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
    Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3B deficiency presenting as severe combined immune deficiency: A case report.
    Mehawej C; Khalife H; Hanna-Wakim R; Dbaibo G; Farra C
    Clin Immunol; 2020 Jun; 215():108453. PubMed ID: 32360517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells.
    Huang K; Wu Z; Liu Z; Hu G; Yu J; Chang KH; Kim KP; Le T; Faull KF; Rao N; Gennery A; Xue Z; Wang CY; Pellegrini M; Fan G
    Hum Mol Genet; 2014 Dec; 23(24):6448-57. PubMed ID: 25027325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in ICF syndrome: evidence for genetic heterogeneity.
    Wijmenga C; Hansen RS; Gimelli G; Björck EJ; Davies EG; Valentine D; Belohradsky BH; van Dongen JJ; Smeets DF; van den Heuvel LP; Luyten JA; Strengman E; Weemaes C; Pearson PL
    Hum Mutat; 2000 Dec; 16(6):509-17. PubMed ID: 11102980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
    Bilgic Eltan S; Nain E; Catak MC; Ezen E; Sefer AP; Karimi N; Kiykim A; Kolukisa B; Baser D; Bulutoglu A; Kasap N; Yorgun Altunbas M; Yalcin Gungoren E; Kendir Demirkol Y; Kutlug S; Hancioglu G; Dilek F; Yildiran A; Ozen A; Karakoc-Aydiner E; Erman B; Baris S
    J Clin Immunol; 2023 Dec; 44(1):26. PubMed ID: 38129713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis.
    Kaya N; Al-Muhsen S; Al-Saud B; Al-Bakheet A; Colak D; Al-Ghonaium A; Al-Dhekri H; Al-Mousa H; Arnaout R; Al-Owain M; Iqbal M
    J Clin Immunol; 2011 Apr; 31(2):245-52. PubMed ID: 21120685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
    Hansen RS; Wijmenga C; Luo P; Stanek AM; Canfield TK; Weemaes CM; Gartler SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14412-7. PubMed ID: 10588719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome.
    Blanco-Betancourt CE; Moncla A; Milili M; Jiang YL; Viegas-Péquignot EM; Roquelaure B; Thuret I; Schiff C
    Blood; 2004 Apr; 103(7):2683-90. PubMed ID: 14645008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.